Cognition Therapeutics, Inc. (CGTX) Operating income 2020–2025
Cognition Therapeutics, Inc. (CGTX) annual operating income history from SEC filings — each fiscal year as reported.
-$47.8MFY2025 · since FY2020: -$17.4M → -$47.8M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$47.8M | +11.4% |
| FY2024 | -$54.0M | -6.4% |
| FY2023 | -$50.7M | -16.5% |
| FY2022 | -$43.6M | -52.3% |
| FY2021 | -$28.6M | -64.3% |
| FY2020 | -$17.4M | — |
Source: SEC XBRL filings · For reference only · Not investment advice